Cardarine (GW501516) is a PPARδ receptor agonist that was initially researched for potential therapeutic benefits but has not been approved for human use by any regulatory authority (e.g., FDA, EMA). It is important to emphasize that Cardarine is not safe for human consumption, as animal studies linked it to rapid cancer development at various doses. Despite anecdotal use in fitness communities for endurance and fat loss, its risks far outweigh any unproven benefits.
Key Points:
1.No Approved Dose: There is no medically endorsed dosage, as it is not approved for human use.
2.Clinical Trial Data: Studies in humans used doses ranging from 2.5 mg to 10 mg daily, but these trials were discontinued due to safety concerns.
3.Anecdotal Use: Some individuals report using 10–20 mg daily, often split into two doses. However, this is based on unverified, unofficial sources and carries significant risk.
4.Cancer Risk: Animal studies showed tumor growth even at low doses. Human risks are unknown but concerning.
5.Legal Status: Banned by the World Anti-Doping Agency (WADA) and regulated in some countries.
6.Strong Recommendation:
Avoid using Cardarine entirely. If considering it for any purpose, consult a healthcare professional first-though they will likely advise against it due to safety and ethical concerns. Prioritize approved, safe methods for fitness or health goals.
